Abstract

The present discourse links the electrical and chemical properties of the brain with neurotransmitters and movement behaviors to further elucidate strategies to diagnose and treat brain disease. Neuromolecular imaging (NMI), based on electrochemical principles, is used to detect serotonin in nerve terminals (dorsal and ventral striata) and somatodendrites (ventral tegmentum) of reward/motor mesocorticolimbic and nigrostriatal brain circuits. Neuronal release of serotonin is detected at the same time and in the same animal, freely moving and unrestrained, while open-field behaviors are monitored via infrared photobeams. The purpose is to emphasize the unique ability of NMI and the BRODERICK PROBE® biosensors to empirically image a pattern of temporal synchrony, previously reported, for example, in Aplysia using central pattern generators (CPGs), serotonin and cerebral peptide-2. Temporal synchrony is reviewed within the context of the literature on central pattern generators, neurotransmitters and movement disorders. Specifically, temporal synchrony data are derived from studies on psychostimulant behavior with and without cocaine while at the same time and continuously, serotonin release in motor neurons within basal ganglia, is detected. The results show that temporal synchrony between the neurotransmitter, serotonin and natural movement occurs when the brain is NOT injured via, e.g., trauma, addictive drugs or psychiatric illness. In striking contrast, in the case of serotonin and cocaine-induced psychostimulant behavior, a different form of synchrony and also asynchrony can occur. Thus, the known dysfunctional movement behavior produced by cocaine may well be related to the loss of temporal synchrony, the loss of the ability to match serotonin in brain with motor activity. The empirical study of temporal synchrony patterns in humans and animals may be more relevant to the dynamics of motor circuits and movement behaviors than are studies of static parameters currently relied upon within the realms of science and medicine. There are myriad applications for the use of NMI to discover clinically relevant diagnoses and treatments for brain disease involving the motor system.

Highlights

  • The present discourse links the electrical and chemical properties of the brain with neurotransmitters and movement behaviors to further elucidate strategies to diagnose and treat brain disease

  • The most important findings are that (a) temporal synchrony between brain neurotransmitter and behavior occurs when endogenous serotonin release in basal ganglia is imaged on line with natural behaviors and (b) psychostimulant-induced behavior, monitored on line while serotonin release is imaged in basal ganglia, produces a different form of synchrony and/or temporal asynchrony

  • Described in this discourse is a dynamic concept of temporal synchrony in natural versus drug-induced movement behavior

Read more

Summary

The Basal Ganglia

In order to examine NMI as this biotechnology relates to the experience of temporal synchrony, let us first look at the basal ganglia. The basal ganglia, comprised of basal nuclei are paired subcortical masses or nuclei of gray matter that include the dorsal striatum, (caudate putamen and the globus pallidum) and the ventral striatum. It was found that Lovenox® a medication for stroke, increased serotonin release in basal ganglia of stroked animals on line, in vivo, with increased blood flow In these studies, NMI simultaneously and selectively imaged neuronal serotonin release in the motor circuit of the murine brain, the dorsal striatum while at the same time, Dual Laser Doppler sensors monitored blood flow [11]. NMI simultaneously and selectively imaged neuronal serotonin release in the motor circuit of the murine brain, the dorsal striatum while at the same time, Dual Laser Doppler sensors monitored blood flow [11] These small gray-matter nuclei, basal nuclei, comprise the basal ganglia. (5) inhibit unwanted movement, (6) adapt to novel or reward movement and (7) motor learning and planning [10]

The Cortico-Basal Ganglia Network
NMI in the Dorsal and Ventral Striatum
Serotonin Is a Neuromodulator for CPGs
Serotonin Is a Neuromodulator for Psychostimulant-Directed Movement
Serotonin Is a Neuromodulator in Spinal Cord Injury
10. Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call